Rapid Micro Biosystems (RPID) Other Non-Current Assets (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Other Non-Current Assets of $284000.0 for Q1 2026, down 10.97% sequentially from $319000.0 in Q4 2025, and down 29.0% YoY from $400000.0 in Q1 2025.
Rapid Micro Biosystems (RPID) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Other Non-Current Assets for 7 years, with the latest figure at $284000.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 29.0% year-over-year to $284000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $284000.0 (down 29.0% YoY) and the FY2025 annual result came in at $319000.0, down 12.6% from the prior year.
- Other Non-Current Assets declined to $284000.0 in Q1 2026 per RPID's latest filing, from $319000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.4 million in Q2 2022 and troughed at $211000.0 in Q3 2025.
- A 5-year average of $381764.7 and a median of $284000.0 in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets surged 386.27% in 2022, then sank 79.44% in 2023.
- Over 5 years, Other Non-Current Assets stood at $284000.0 in 2022, then gained by 5.63% to $300000.0 in 2023, then climbed by 21.67% to $365000.0 in 2024, then dropped by 12.6% to $319000.0 in 2025, then fell by 10.97% to $284000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $284000.0, $319000.0, and $211000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Rapid Micro Biosystems | 80.50 Mn | 60.73 Mn | 1.21 Mn | 284,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 284,000.00 |
| Mar 31, 2026 | 284,000.00 |
| Dec 31, 2025 | 319,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 284,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 365,000.00 |
| Sep 30, 2024 | 642,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Dec 31, 2022 | 284,000.00 |
| Sep 30, 2022 | 284,000.00 |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 284,000.00 |
| Dec 31, 2021 | 284,000.00 |
| Sep 30, 2021 | 284,000.00 |